Clinical Trials
39 trialsProspective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
National Institutes of Health Clinical Center (CC)
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
National Institutes of Health Clinical Center (CC)
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
National Institutes of Health Clinical Center (CC)
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
National Cancer Institute (NCI)
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
National Institutes of Health Clinical Center (CC)
Collection of Clinical Data and Specimens for Research on Head and Neck and Communication Disorders
National Institutes of Health Clinical Center (CC)
ECI301 and Radiation for Advanced or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Stem Cell Transplantation for Metastatic Solid Tumors
National Institutes of Health Clinical Center (CC)
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
National Institutes of Health Clinical Center (CC)
Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery
National Institutes of Health Clinical Center (CC)
Comparing Magnetic Resonance Imaging/Spectroscopy Techniques
National Institutes of Health Clinical Center (CC)
Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
National Institutes of Health Clinical Center (CC)
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Costa Rican Natural History Study of HPV and Cervical Neoplasia
National Institutes of Health Clinical Center (CC)
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
National Institutes of Health Clinical Center (CC)
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
National Institutes of Health Clinical Center (CC)
HGS-ETR2 to Treat Children With Solid Tumors
National Institutes of Health Clinical Center (CC)
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
The Natural History of Solid Organ Cancer Stem Cells (SOCSC)
National Institutes of Health Clinical Center (CC)
Enzastaurin to Treat Recurrent Brain Tumor
National Institutes of Health Clinical Center (CC)
Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
National Institutes of Health Clinical Center (CC)
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Effect of Ketamine on Fatigue Following Cancer Therapy
National Institutes of Health Clinical Center (CC)
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
National Institutes of Health Clinical Center (CC)
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor
National Institutes of Health Clinical Center (CC)
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
National Institutes of Health Clinical Center (CC)
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
National Institutes of Health Clinical Center (CC)
Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures
National Institutes of Health Clinical Center (CC)
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
National Institutes of Health Clinical Center (CC)
p53 Vaccine for Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Drosophila-generated CTL
National Institutes of Health Clinical Center (CC)
Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)
National Center for Complementary and Integrative Health (NCCIH)
Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Vandetanib to Treat Advanced Kidney Cancer
National Institutes of Health Clinical Center (CC)
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
National Institutes of Health Clinical Center (CC)